Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine

This study has been completed.
Sponsor:
Collaborator:
Ministry of Health, British Columbia
Information provided by (Responsible Party):
Simon Dobson, University of British Columbia
ClinicalTrials.gov Identifier:
NCT00501137
First received: July 11, 2007
Last updated: April 16, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Publications: